Use of proliferation rate, p53 staining and perforating elastic fibers in distinguishing keratoacanthoma from hypertrophic lichen planus: A pilot study

Journal of Cutaneous Pathology

Volumn 39, Issue 2, 2012, Pages 243-250

  Bowen, Anneli R ^a   Burt, Lindsay ^a   Boucher, Kenneth ^a   Tristani Firouzi, Payam ^a   Florell, Scott R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Elastic; Keratoacanthoma; Lichen planus; P53

Indexed keywords

PROTEIN P53; TP53 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; COMPARATIVE STUDY; ELASTIC TISSUE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; LICHEN PLANUS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PILOT STUDY; RETROSPECTIVE STUDY; SKIN;

ADULT; AGED; AGED, 80 AND OVER; CELL PROLIFERATION; ELASTIC TISSUE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; LICHEN PLANUS; MALE; MIDDLE AGED; PILOT PROJECTS; RETROSPECTIVE STUDIES; SKIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84859270328     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01834.x     Document Type: Article

References (37)

1. Chave TA, Graham-Brown RA.Keratoacanthoma developing in hypertrophic lichen planus. Br J Dermatol 2003 148: 592. (Pubitemid 36461344)
2. Allen JV, Callen JP. Keratoacanthomas arising in hypertrophic lichen planus. A case report. Arch Dermatol 1981; 117: 519.
3. Badell A, Marcoval J, Gallego I, Moreno A, Peyri J. Keratoacanthoma arising in hypertrophic lichen planus. Br J Dermatol 2000; 142: 380.
4. Giesecke LM, Reid CM, James CL, Huilgol SC. Giant keratoacanthoma arising in hypertrophic lichen planus. Australas J Dermatol 2003; 44: 267.
5. Team RDC. A language and environment for statistical computing, Vienna, 2010.
6. Sigurgeirsson B, Lindelof B. Lichen planus and malignancy. An epidemiologic study of 2071 patients and a review of the literature. Arch Dermatol 1991; 127: 1684.
7. Friedl TK, Flaig MJ, Ruzicka T, Rupec RA. Verrucous squamous cell carcinoma complicating hypertrophic lichen planus : three case reports and review of the literature. Hautarzt 2010; 62: 40.
8. Kossard S, Thompson C, Duncan GM. Hypertrophic lichen planus-like reactions combined with infundibulocystic hyperplasia. Arch Dermatol 2004; 140: 1262.
9. Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol 1993; 15: 332.
10. Weedon D. Skin pathology, 3rd ed. New York: Churchill Livingstone, 2010.
11. Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the p53 network. J Cell Sci 2003; 116(Pt 20): 4077.
12. Ebrahimi M, Boldrup L, Coates PJ, Wahlin YB, Bourdon JC, Nylander K. Expression of novel p53 isoforms in oral lichen planus. Oral Oncol 2008; 44: 156.
13. Batinac T, Zamolo G, Jonjic N, Gruber F, Petrovecki M. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases. Tumori 2004; 90: 120.
14. Bagazgoitia L, Cuevas J, Juarranz A. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease. J Eur Acad Dermatol Venereol 2010; 24: 228.
15. Hussein MR, Al-Badaiwy ZH, Guirguis MN. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions. J Cutan Pathol 2004; 31: 643.
16. Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010; 31: 37.
17. Sakiz D, Turkmenoglu TT, Kabukcuoglu F. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin. Pathol Res Pract 2009; 205: 589.
18. Batinac T, Zamolo G, Coklo M, Hadzisejdic I, Stemberger C, Zauhar G. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma. Pathol Res Pract 2006; 202: 599.
19. Girod SC, Kramer C, Knufermann R, Krueger GR. p53 expression in the carcinogenesis in the oral mucosa. J Cell Biochem 1994; 56: 444.
20. Schifter M, Jones AM, Walker DM. Epithelial p53 gene expression andmutational analysis, combined with growth fraction assessment, in oral lichen planus. J Oral Pathol Med 1998; 27: 318.
21. Lee JJ, Kuo MY, Cheng SJ, et al. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 471.
22. Hirota M, Ito T, Okudela K, et al. Cell proliferation activity and the expression of cell cycle regulatory proteins in oral lichen planus. J Oral Pathol Med 2002; 31: 204.
23. Chaiyarit P, Ma N, Hiraku Y, et al. Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci 2005; 96: 553.
24. Acay RR, Felizzola CR, de Araujo N, de Sousa SO. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67. Oral Oncol 2006; 42: 475.
25. Ogmundsdottir HM, Hilmarsdottir H, Astvaldsdottir A, Johannsson JH, Holbrook WP. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD. Eur J Oral Sci 2002; 110: 192.
26. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31: 13.
27. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002; 40: 2.
28. Binato M, Fagundes R, Gurski R, Meurer L, Edelweiss MI. Immunohistochemical overexpression of the p53 protein and Ki-67 (MIB-1) antigen in patients with GERD and chronic esophagitis. Appl Immunohistochem Mol Morphol 2010; 18: 236.
29. Sipos F, Molnar B, Zagoni T, Tulassay Z. Changes in cell kinetics and clinical course in inflammatory bowel diseases. Orv Hetil 2002; 143: 1175.
30. Wang W, Bergh A, Damber JE. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 2009; 69: 1378.
31. Wang W, Bergh A, Damber JE. Increased p53 immunoreactivity in proliferative inflammatory atrophy of prostate is related to focal acute inflammation. APMIS 2009; 117: 185.
32. Bowen AR, Hanks AN, Murphy KJ, Florell SR,GrossmanD. Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias. Am J Dermatopathol 2004; 26: 177.
33. Montebugnoli L, Farnedi A, Marchetti C, Magrini E, Pession A, Foschini MP. High proliferative activity and chromosomal instability in oral lichen planus. Int J Oral Maxillofac Surg 2006; 35: 1140.
34. Schwartz RA,RichfieldDF. Pseudoxanthoma elasticum with transepidermal elimination. Arch Dermatol 1978; 114: 279.
35. Kazakis AM, Parish WR. Periumbilical perforating pseudoxanthoma elasticum. J Am Acad Dermatol 1988; 19(2 Pt 2): 384.
36. Goette DK. Transepidermal elimination of actinically damaged connective tissue. Int J Dermatol 1984; 23: 669.
37. Ohashi A, Ishizaki M, Kawana S, Fukuda Y. Mechanism of transepithelial elimination of elastic fibers in keratoacanthoma. Pathol Int 2004; 54: 585.